Paige vs Lunit vs Shukun 数坤科技 vs Harrison.ai
A side-by-side look at scores, pricing and features — with RECATOOLS' ASEAN-aware verdict for each.
Paige
Cancer pathology AI behind the FDA-authorised Paige Prostate, now part...
Visit
|
Lunit
KOSDAQ-listed Korean AI for breast and chest cancer screening
Visit
|
Shukun 数坤科技
Beijing imaging AI with China's most Class III approvals, by its own c...
Visit
|
Harrison.ai
Sydney radiology AI covering up to 124 chest X-ray findings
Visit
|
|
|---|---|---|---|---|
| RECATOOLS Score | 8.2 / 10 | 6.7 / 10 | 6.8 / 10 | 8.2 / 10 |
| Capability | ||||
| Value for money | ||||
| Ease of use | ||||
| ASEAN readiness | ||||
| API quality | ||||
| Pricing | Custom | Enterprise | Enterprise | Enterprise |
| Free tier | — | — | — | — |
| Paid from | Quoted per deployment; 30-day trial of the diagnostic suites on request | No public $ price — quoted per institution via Lunit sales and imaging partners | Quoted on request (hospital and distributor sales, trial by application) | Enterprise contracts quoted on request |
| Has API | ✓ | ✗ | ✗ | ✓ |
| Open source | ✗ | ✗ | ✗ | ✗ |
| Free to use | ✗ | ✗ | ✗ | ✗ |
| Users | In clinical use at hospitals and labs worldwide; training data spans 800+ labs across 45 countries | — | — | 3,400+ clinicians at 1,000+ sites across 40+ countries |
| Founded | 2017 | 2015 | 2017 | 2018 |
| Maker | Tempus AI | — | — | Dr. Aengus Tran (CEO) and Dimitry Tran (co-founder) |
| Verdict | Paige has the strongest regulatory record in AI pathology: a 2021 FDA De Novo authorisation for Paige Prostate, Breakthrough designations, and CE and UKCA marks across its suites. The evidence deserves careful reading, t... |
Lunit is one of the few medical-AI vendors with substantial revenue behind it: KRW 45.8 billion in the first half of 2026, up 23%, almost all earned abroad, though it is still loss-making and completed a KRW 211.5 billio... |
Shukun's case rests on approvals and breadth: 18 Chinese Class III certificates by its count, MDR CE marks across cardiac, stroke and other tools, PMDA approvals in Japan and three FDA 510(k) clearances, including Corona... |
Harrison.ai offers unusually broad coverage in one product: up to 124 chest X-ray and 130 head CT findings with worklist prioritisation, deployed at more than 1,000 sites and in every public emergency department in Hong... |
| Full review → | Full review → | Full review → | Directory listing → |
Comparisons cover up to 4 tools. Scores are RECATOOLS editorial assessments; verify current pricing on each vendor's site.